Psychedelics are substances (natural or laboratory made) which cause profound changes in a one’s perceptions of reality. While under the influence of hallucinogens, users might hallcuniate visually and auditorily.

This is a commonly used substance with well known effects, but that does not guarantee the substance will be safe. The safety profile has been established based on usage data commonly reported by others.

Disclaimer: Psychedelic drugs offer some of the most powerful and intense psychological experiences. Additionally these substances are illegal in many places. We understand that even though these substances are illegal, their use occurs frequently. We do not condone breaking of the law. By providing accurate information about these substances, we encourage the user to make responsible decisions and practice harm reduction.

Description

Cannabis Also known as:

(-)-δ9-trans-Tetrahydrocannabinol

Δ9-Tetrahydrocannabinol

Δ9--THC

(-)-trans-δ9-Tetrahydrocannabinol

(-)-trans-δ9-THC

(-)-δ 9-Tetrahydrocannabinol

(-)-δ9-Tetrahydrocannabinol

(-)-δ9-Tetrahydrocannabinol

(-)-δ9-THC

(-)-δ9-trans-Tetrahydrocannabinol

(6aR,10aR)-6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol[ACD/IUPAC Name]

(6aR,10aR)-6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol[German][ACD/IUPAC Name]

(6aR,10aR)-6,6,9-Triméthyl-3-pentyl-6a,7,8,10a-tétrahydro-6H-benzo[c]chromén-1-ol[French][ACD/IUPAC Name]

1972-08-3[RN]

200-578-6[EINECS]

200-659-6[EINECS]

6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-

6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR,10aR)-[ACD/Index Name]

6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-

Dronabinol[INN][USAN][USP]

Dronabinolum[Latin]

Marinol[Trade name]

Marinol (TN)

MFCD00083207[MDL number]

Tetrahydrocannabinol[Wiki]

δ(9)-Tetrahydrocannabinol

δ1-Tetrahydrocannabinol

δ1-THC

δ-9-TETRAHYDROCANNABINOL

δ9-THC

δ9-THC

(-)- δ 9-Tetrahydrocannabinol

(-)-(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol

(-)-3,4-trans-δ1-Tetrahydrocannabinol

(-)-trans-δ 1-Tetrahydrocannabinol

(-)-trans-δ 9-Tetrahydrocannabinol

(-)-trans-δ 9-THC

(-)-trans-δ1-Tetrahydrocannabinol

(-)-trans-δ9-Tetrahydrocannabinol

(-)-δ 1-Tetrahydrocannabinol

(-)-δ 9-THC

(-)-δ 9-trans-Tetrahydrocannabinol

(-)-δ(sup 1)-3,4-trans-Tetrahydrocannabinol

(-)-δ(sup9)-trans-Tetrahydrocannabinol

(-)-δ1-Tetrahydrocannabinol

(-)-δ1-Tetrahydrocannabinol

(-)-δ9-(trans)-Tetrahydrocannabinol

(10R,10aR)-6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol

(6aR,10aR)-3-amyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol

(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol

(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6H,6aH,7H,8H,10aH-benzo[c]isochromen-1-ol

(6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol

(6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol

(6aR-trans)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol

(L)-δ 1-Tetrahydrocannabinol

(l)-δ(sup 1)-Tetrahydrocannabinol

(l)-δ1-Tetrahydrocannabinol

(L)-δ1-Tetrahydrocannabinol

1-trans-δ 9-Tetrahydrocannabinol

1-trans-δ(sup 9)-Tetrahydrocannabinol

1-trans-δ(sup9)-tetrahydrocannabinol

1-trans-δ(sup9)-tetrahydrocannabinol

1-trans-δ9-Tetrahydrocannabinol

1-TRANS-δ-9-TETRAHYDROCANNABINOL

3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,d)pyran-1-ol

6,6,9-Trimethyl-3-pentyl-7,8,9,10-tetrahydro-6H-dibenzo(b,d)pyran-1-ol

6,6,9-Trimethyl-3-pentyl-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

6aR,7,8,10aR-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol

6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR,10aR)-

6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, trans-

6H-Dibenzo[b, d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-

6H-Dibenzo[b, d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-

6H-Dibenzo[b, d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, trans-

6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8, 10a-tetrahydro-6,6,9-trimethyl-3-pentyl-

6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6, 9-trimethyl-3-pentyl-, (6aR-trans)-

6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, trans-

Cannabinol, 1-trans-δ(sup 9)-tetrahydro-

Cannabinol, 1-trans-δ(sup9)-tetrahydro-

Cannabinol, δ1-tetrahydro-

Cannabinol, δ1-tetrahydro-

Deltanyne

Exocyclic δ (9)(11)-Tetrahydrocannabiol

Î”9-THC

Î”9-THC (CRM)

L-trans-δ 9-Tetrahydrocannabinol

L-trans-δ9-Tetrahydrocannabinol

L-trans-δ9-Tetrahydrocannabinol

L-δ 1-trans-Tetrahydrocannabinol

L-δ1-Tetrahydrocannabinol

l-δ1-trans-Tetrahydrocannabinol

L-δ1-trans-Tetrahydrocannabinol

Marinol®

Maxepa

Primolut

Syndros

Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol

Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol

Tetrahydrocannabinol δ9

Tetranabinex

trans-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol

trans-δ (-)-9-Tetrahydrocannabinol

trans-δ 9-Tetrahydrocannabinol

trans-δ9-Tetrahydrocannabinol

trans-δ9-Tetrahydrocannabinol

δ 1-Tetrahydrocannabinol

δ 1-THC

δ 9-Tetrahydrocannabinol

δ 9-THC

δ 9-trans-Tetrahydrocannabinol

δ(1)-Tetrahydrocannabinol

δ(9)-Tetrahydrocannibinol

δ(9)-THC

δ(sup 1)-Tetrahydrocannabinol

δ(sup 1)-thc

δ(sup 9)-tetrahydrocannabinol

δ(sup 9)-thc

δ(sup9)-THC

δ1-Tetrahydrocannabinol

δ1-Tetrahydrocannabinol (VAN)

δ1-THC

δ9-Tetrahydrocannabinol

δ9-Tetrahydrocannabinol

Δ9-tetrahydrocannabinol

δ9-Tetrahydrocannabinol (VAN)

δ-9-THC

δ-9-THC

Δ9-THC

δ9-trans-Tetrahydrocannabinol

δ9-trans-Tetrahydrocannabinol

A common and widely used psychoactive plant, which is beginning to enjoy legal status for medical and even recreational use in some parts of the world. Usually smoked or eaten, primary effects are relaxation and an affinity towards food - a state described as being ‘stoned.’

Summary

The principal psychoactive constituent of cannabis is tetrahydrocannabinol (THC), which makes up one of 483 known compounds in the plant, including at least 84 other cannabinoids such as cannabidiol (CBD), cannabinol (CBN), tetrahydrocannabivarin (THCV), and cannabigerol (CBG). The genus cannabis is indigenous to central Asia and the Indian subcontinent. The earliest recorded uses of cannabis date from the 3rd millennium BC.

At least three species are recognized: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. In modern times, cannabis is used for recreational or medicinal and religious or spiritual purposes. Since the early 20th century, cannabis has been subject to legal restrictions with the possession, use, and sale of cannabis preparations containing psychoactive cannabinoids currently illegal in most countries.

However, there is a recent growing trend towards decriminalization and legalization and the plant is legal in some states and countries such as Amsterdam. According to a United Nations report, cannabis is the most used illicit drug in the world. In 2004, the U.

N. estimated that global consumption patterns of cannabis indicated that approximately 4% of the adult world population (162 million people) used cannabis annually and that approximately 0. 6% (22.

5 million) of people used cannabis daily.

History

Tombs in China reveal humans were smoking cannabis 2500 years ago. The potency of illicit cannabis plant material has consistently increased over time since 1995 from ~4% in 1995 to ~12% in 2014. The cannabidiol content has decreased on average from ~.28% in 2001 to <.15% in 2014, resulting in a change in the ratio of Δ9-tetrahydrocannabinol to cannabidiol from 14 times in 1995 to ~80 times in 2014.

Chemistry

Cannabis contains more than 460 compounds; at least 80 of these are cannabinoids, chemical compounds that interact with cannabinoid receptors in the brain.

The most common cannabinoids are listed below:

Common Name	(-)-.DELTA.9-trans-Tetrahydrocannabinol
Systematic name	(-)-δ9-trans-Tetrahydrocannabinol
Formula	C_{21}H_{30}O_{2}
SMILES	CCCCCc1cc(c2c(c1)OC([C@H]3[C@H]2C=C(CC3)C)(C)C)O
Std. InChi
Std. InChiKey
Avg. Mass	314.4617 Da
Molecular Weight	314.4617
Monoisotopic Mass	314.224579 Da
Nominal Mass	314
ChemSpider ID	15266

Become an Exclusive Member For Free

Become a member now, sign up, and get free updates, news articles, and the latest happenings in the Psychedelic World.

Dose Chart

Smoked
Light	10-20mg
Common	20-60mg
Strong	60-100mg+

Duration Chart

Smoked
Onset	1-10 minutes
Duration	1-4 hours
After-effects	2-24 hours

Interactions

Caution

Mushrooms
- Cannabis has an unexpectedly strong and somewhat unpredictable synergy with psychedelics.
LSD
- Cannabis has an unexpectedly strong and somewhat unpredictable synergy with psychedelics.
DMT
- Cannabis has an unexpectedly strong and somewhat unpredictable synergy with psychedelics.
Mescaline
- Cannabis has an unexpectedly strong and somewhat unpredictable synergy with psychedelics.
DOx
- Cannabis has an unexpectedly strong and somewhat unpredictable synergy with psychedelics.
NBOMes
- Cannabis has an unexpectedly strong and somewhat unpredictable synergy with psychedelics.
2C-x
- Cannabis has an unexpectedly strong and somewhat unpredictable synergy with psychedelics.
2C-T-x
- Cannabis has an unexpectedly strong and somewhat unpredictable synergy with psychedelics.
αMT
- Cannabis has an unexpectedly strong and somewhat unpredictable synergy with psychedelics. Small amounts can reduce nausea with aMT but take care.
5-MeO-xxT
- Cannabis has an unexpectedly strong and somewhat unpredictable synergy with psychedelics.
Amphetamines
- Stimulants increase anxiety levels and the risk of thought loops which can lead to negative experiences
Cocaine
- Stimulants increase anxiety levels and the risk of thought loops which can lead to negative experiences

Dangerous

Low Synergy

Benzodiazepines

No Synergy

Caffeine
SSRIs

High Synergy

Ketamine
MXE
DXM
PCP
N2O
MDMA
- Large amounts of cannabis may cause strong and somewhat unpredictable experiences in combination with MDMA. Cannabis should be saved for towards the end of the experience if possible.
Alcohol
- In excess, this combination can cause nausea.
GHB/GBL
Opioids
Tramadol
MAOIs

Legal Status

The legality of cannabis for medical and recreational use varies by country, in terms of its possession, distribution, and cultivation, and (in regards to medical) how it can be consumed and what medical conditions it can be used for. These policies in most countries are regulated by the United Nations Single Convention on Narcotic Drugs that was ratified in 1961, along with the 1971 Convention on Psychotropic Substances and the 1988 Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances. The World Health Organization (WHO) is calling for whole-plant marijuana, as well as cannabis resin, to be removed from Schedule IV—the most restrictive category of a 1961 drug convention signed by countries from around the world.

Responsible use

Hallucinogens

Cannabinoids

Synthetic cannabinoids

Sources

References

References

http://en.wikipedia.orghttps://psychonautwiki.org/wiki//Marijuana_(word)
http://www.merriam-webster.com/dictionary/weed
http://www.merriam-webster.com/dictionary/pot
http://www.merriam-webster.com/dictionary/grass
http://www.merriam-webster.com/dictionary/herb
Ethan B Russo (2013). Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential. Routledge. p. 28. ISBN 978-1-136-61493-4. | http://books.google.co.uk/books?id=qH-2Lj9x7L4C&pg=PP28&redir_esc=y#v=onepage&q&f=false
Antidepressant-like effect of ?9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866040/
Distinct Effects of ?9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing | http://archpsyc.jamanetwork.com/article.aspx?articleid=482939
A. ElSohly, Mahmoud (2007). Marijuana and the Cannabinoids. Humana Press. p. 8. ISBN 1-58829-456-0. Retrieved 2 May 2011.
Martin Booth (2003). Cannabis: A History. Transworld. p. 36. ISBN 978-1-4090-8489-1.
http://www.erowid.org/plants/cannabis/cannabis_law.shtml
http://www.unodc.org/unodc/en/data-and-analysis/WDR-2010.html
http://www.unodc.org/pdf/WDR_2006/wdr2006_chap2_biggest_market.pdf
https://advances.sciencemag.org/content/5/6/eaaw1391
https://www.sciencedirect.com/science/article/pii/S0006322316000457
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987131/
Cannabinoids in medicine: A review of their therapeutic potential | http://www.doctordeluca.com/Library/WOD/WPS3-MedMj/CannabinoidsMedMetaAnalysis06.pdf
Phytocannabinoids, CNS cells and development: A dead issue? | http://onlinelibrary.wiley.com/doi/10.1111/j.1465-3362.2009.00102.x/abstract
Cannabinoid Analgesia as a Potential New Therapeutic Option in the Treatment of Chronic Pain | http://aop.sagepub.com/content/40/2/251
The Pharmacologic and Clinical Effects of Medical Cannabis | http://onlinelibrary.wiley.com/doi/10.1002/phar.1187/abstract
Cannabinoids in medicine: A review of their therapeutic potential | http://www.doctordeluca.com/Library/WOD/WPS3-MedMj/CannabinoidsMedMetaAnalysis06.pdf
Cannabinoids in medicine: A review of their therapeutic potential | http://www.doctordeluca.com/Library/WOD/WPS3-MedMj/CannabinoidsMedMetaAnalysis06.pdf
Medical Consequences of Marijuana Use: A Review of Current Literature | http://link.springer.com/article/10.1007/s11920-013-0419-7
Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors
9-Tetrahydrocannabinol and Endogenous Cannabinoid Anandamide Directly Potentiate the Function of Glycine Receptors | http://molpharm.aspetjournals.org/content/69/3/991
Franklin JM, Carrasco GA. Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling. Synapse. 2012;67(3):145-59.
Robson, P. (2001). "Therapeutic aspects of cannabis and cannabinoids". The British Journal of Psychiatry. 178 (2): 107–115. :10.1192/bjp.178.2.107. 0007-1250.
Mechoulam, Raphael; Parker, Linda A.; Gallily, Ruth (2002). "Cannabidiol: An Overview of Some Pharmacological Aspects". The Journal of Clinical Pharmacology. 42 (S1): 11S–19S. :10.1002/j.1552-4604.2002.tb05998.x. 0091-2700.
Mechoulam, R. (1984). Cannabinoids as therapeutic agents. Boca Raton, FL: CRC Press. ISBN 0-8493-5772-1.
Investigating the Neuroendocrine and Behavioral Controls of Cannabis-Induced Feeding Behavior. JF Davis, PQ Choi, J Kunze, P Wahl, Washington State University Pullman, WA, USA. Presented July 2018, Society for the Study of Ingestive Behavior, Bonita Springs, FL.
Tetrahydrocannabivarin (THCV): A Cannabinoid Fighting Obesity | https://www.medicaljane.com/2013/08/27/tetrahydrocannabivarin-thcv-a-cannabinoid-fighting-obesity/
The Pharmacologic and Clinical Effects of Medical Cannabis | http://onlinelibrary.wiley.com/doi/10.1002/phar.1187/abstract;jsessionid=1E004D7B7E2B5CA792E75A6E83EEC59C.f03t01
The Therapeutic Potential of Cannabis and Cannabinoids | http://www.aerzteblatt.de/int/archive/article?id=127603
https://psychonautwiki.orghttps://psychonautwiki.org/wiki//Laughter_fits
Systematic Review and Meta-analysis of Cannabis Treatment for Chronic Pain | http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4637.2009.00703.x/abstract
Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials | http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2011.03970.x/abstract
Charlotte Figi: The Girl Who is Changing Medical Marijuana Laws Across America | http://www.ibtimes.co.uk/charlotte-figi-girl-who-changing-medical-marijuana-laws-across-america-1453547
On the frontier of medical pot to treat boy's epilepsy | http://articles.latimes.com/2012/sep/13/local/la-me-customized-marijuana-20120914
Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157067/
Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo. (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pubmed/19906779/
An electrophysiological analysis of the anticonvulsant action of cannabidiol on limbic seizures in conscious rats. (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pubmed/477630
Δ⁹-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats. (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pubmed/20196794
Cannabinoids: Defending the Epileptic Brain (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1176332/
Cardiovascular Effects of Cannabis | http://www.idmu.co.uk/canncardio.htm
Is Marijuana an Effective Treatment for Glaucoma? | http://medicalmarijuana.procon.org/view.answers.php?questionID=000140
http://europepmc.org/abstract/med/1147519
Feinberg, I., Jones, R, Walker JM, Cavness, C, March, J. (1975). Effects of high dosage delta-9-tetrahydrocannabinol on sleep patterns in man. Clin Parmacol Ther. 1975; 17(4):458-66.
Causal association between cannabis and psychosis: examination of the evidence - The British Journal of Psychiatry Jan 2004, 184 (2) 110-117 | http://bjp.rcpsych.org/content/184/2/110.short
A Teenager With Agitation: Higher Than She Should Have Climbed - Pediatric Emergency Care: June 2010 - Volume 26 - Issue 6 - pp 462-465 | http://journals.lww.com/pec-online/Abstract/2010/06000/A_Teenager_With_Agitation__Higher_Than_She_Should.16.aspx
High Times in Ag Science: Marijuana More Potent Than Ever | http://www.wired.com/2008/12/high-times-in-a/
http://dictionary.reference.com/browse/Marijuana
http://www.cannabisculture.com/articles/4220.html
EMCDDA (2008). "A cannabis reader: global issues and local experiences". Monograph Series. 8 (1). European Monitoring Centre for Drugs and Drug Addiction, Lisbon, :10.2810/13807
http://books.google.co.uk/books?id=x9Z1QZ5NIEIC&pg=PA78&redir_esc=y
Gloss, D (October 2015). "An Overview of Products and Bias in Research". Neurotherapeutics. 12 (4): 731–4. :10.1007/s13311-015-0370-x. PMC 4604179 . PMID 26202343.
The Cultural/Subcultural Contexts of Marijuana Use at the Turn of the Twenty-First Century | http://books.google.co.uk/books?id=KFMtFv2tmbYC&pg=PA82&redir_esc=y#v=onepage&q&f=false
Allan Tasman; Jerald Kay; Jeffrey A. Lieberman; Michael B. First, Mario Maj (2011). Psychiatry. John Wiley & Sons. p. 9. ISBN 978-1-119-96540-4. | http://books.google.co.uk/books?id=vVG7zz7eaxcC&pg=RA9-PT2217&redir_esc=y#v=onepage&q&f=false
Cannabis and Cannabis Extracts: Greater Than the Sum of Their Parts? | http://www.cannabis-med.org/data/pdf/2001-03-04-7.pdf
Dronabinol | http://chem.sis.nlm.nih.gov/chemidplus/rn/1972-08-3
Marijuana medical handbook | http://books.google.co.uk/books?id=OuAHxDKcpS8C&pg=PA182&redir_esc=y#v=onepage&q&f=false
"Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy" Stephen E. Sallan, M.D., Norman E. Zinberg, M.D., and Emil Frei, III, M.D. DOI: 10.1056/NEJM197510162931603 http://www.nejm.org/doi/pdf/10.1056/NEJM197510162931603
American College of Physicians. Supporting Research into the Therapeutic Role of Marijuana. Philadelphia: American College of Physicians; 2008: Position Paper. (Available from American College of Physicians, 190 N. Independence Mall West, Philadelphia, PA19106.) https://www.acponline.org/system/files/documents/advocacy/current_policy_papers/assets/medmarijuana.pdf
Development of a rational scale to assess the harm of drugs of potential misuse (ScienceDirect) | http://www.sciencedirect.com/science/article/pii/S0140673607604644
Causal association between cannabis and psychosis: examination of the evidence - The British Journal of Psychiatry Jan 2004, 184 (2) 110-117 | http://bjp.rcpsych.org/content/184/2/110.short
Every-Palmer, S. Synthetic cannabinoid use and psychosis: an explorative study. Journal of Drug and Alcohol Dependence 2011.
“Spice” Girls: Synthetic Cannabinoid Intoxication - The Journal of Emergency Medicine Volume 40, Issue 3, March 2011, Pages 296–299 (ScienceDirect) | http://www.sciencedirect.com/science/article/pii/S0736467910008802
A Teenager With Agitation: Higher Than She Should Have Climbed - Pediatric Emergency Care: June 2010 - Volume 26 - Issue 6 - pp 462-465 | http://journals.lww.com/pec-online/Abstract/2010/06000/A_Teenager_With_Agitation__Higher_Than_She_Should.16.aspx
Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use | http://onlinelibrary.wiley.com/doi/10.1111/j.1465-3362.2009.00149.x/abstract
Pharmacology and effects of cannabis: a brief review | http://bjp.rcpsych.org/content/178/2/101
Adverse effects of cannabis | http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(98)05021-1/fulltext
https://www.drugbank.ca/drugs/DB00470
Tetrahydrocannabinols in clinical and forensic toxicology (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pubmed/16225128
Lopez-Quintero C, Pérez de los Cobos J, Hasin DS, et al.: Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend 2011; 115: 120–30 | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069146/
The Pharmacologic and Clinical Effects of Medical Cannabis | http://onlinelibrary.wiley.com/doi/10.1002/phar.1187/abstract
The Effect of Cannabis Compared with Alcohol on Driving | http://onlinelibrary.wiley.com/doi/10.1080/10550490902786934/abstract
Medical Consequences of Marijuana Use: A Review of Current Literature | http://link.springer.com/article/10.1007/s11920-013-0419-7
State of the Art Treatments for Cannabis Dependence (ScienceDirect) | http://www.sciencedirect.com/science/article/pii/S0193953X12000202
Cannabinoid tolerance and dependence | http://www.ncbi.nlm.nih.gov/pubmed/16596793
MARIJUANA AND MEDICINE Assessing the Science Base | http://www.nap.edu/openbook.php?record_id=6376
https://www.ncbi.nlm.nih.gov/pubmed/3902318
Habibi, Roojin; Hoffman, Steven J. (March 2018). "Legalizing Cannabis Violates the UN Drug Control Treaties, But Progressive Countries Like Canada Have Options". Ottawa Law Review. 49 (2). Retrieved 22 July 2018.
Bewley-Taylor, David; Jelsma, Martin; Rolles, Steve; Walsh, John (June 2016). "Cannabis regulation and the UN drug treaties" (PDF). Retrieved 22 July 2018.
https://www.marijuanamoment.net/read-the-world-health-organizations-marijuana-rescheduling-recommendations/

Information made possible with:

PsychonautWiki is a community-driven online encyclopedia that aims to document the field of psychonautics in a comprehensive, scientifically-grounded manner.
Erowid is a non-profit educational & harm-reduction resource with 60 thousand pages of online information about psychoactive drugs
PubChem National Center for Bio Informatics
Chemspider is a free chemical structure database providing fast access to over 34 million structures, properties and associated information.
Wikipedia

Additional APIs were used to construct this information. Thanks to ChemSpider, NCBI, PubChem etc.

Data is constantly updated so please check back later to see if there is any more available information on this substance.

Cannabis

Description

Summary

History

Chemistry

Dose Chart

Duration Chart

Interactions

Caution

Dangerous

Low Synergy

No Synergy

High Synergy

Legal Status

Sources

References

Tags